BBNX NASDAQ
Beta Bionics, Inc.
1W: -11.8%
1M: -2.4%
3M: +13.4%
YTD: -35.2%
1Y: -6.2%
$18.96
+0.09 (+0.48%)
Weekly Expected Move ±13.4%
$14
$16
$19
$22
$24
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (95)
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
$1.2M yolo into $TNDM (Tandem Diabetes)
$1.2M yolo into $TNDM (Tandem Diabetes)
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
Beta Bionics (NASDAQ:BBNX) Insider Sells $58,300.00 in Stock
Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) with Significant Losses to Seek a Leadership Role Before November 3, 2026
Beta Bionics Stock Surges on FDA Clearance for Mint Patch Pump
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?
At a glance: stocks gapping down premarket
Beta Bionics shares fall as company prices $150M stock offering at $17.25/share
Beta Bionics plans $125M public offering; shares down
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX
BBNX Investor Alert: Johnson Fistel Encourages Beta Bionics, Inc. Investors to Contact the Firm Ahead of November 3, 2026 Lead Plaintiff Deadline
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
BlackRock Inc. Takes $52.34 Million Position in Beta Bionics, Inc. $BBNX
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of “Moderate Buy” from Analysts
Beta Bionics, Inc. (BBNX) Reports Q2 Loss, Tops Revenue Estimates
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
Beta Bionics, Inc. (BBNX) Investigation: Johnson Fistel Investigates Investor Losses Following Slower New Patient Start Growth
Beta Bionics, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in BBNX Due to Possible Violations of Securities Laws
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
Analysts Set Beta Bionics, Inc. (NASDAQ:BBNX) Target Price at $22.00
Beta Bionics to Present at the Bank of America Securities Health Care Conference
Beta Bionics (NASDAQ:BBNX) Shares Gap Up on Earnings Beat
Beta Bionics, Inc. Q1 2026 Earnings Call Summary
Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5%
Beta Bionics BBNX Q1 2026 Earnings Transcript
Beta Bionics Q1 2026 Earnings Call Transcript
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates
Beta Bionics GAAP EPS of -$0.49 beats by $0.01, revenue of $27.6M beats by $0.63M
Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Earnings Scheduled For April 21, 2026
Quant snapshot: Eni, Alpine Income Property Trust lead top-rated names as Crown Castle, Goosehead Insurance lag
Beta Bionics (NASDAQ:BBNX) Stock Price Down 4.9% After Analyst Downgrade
Beta Bionics, Inc. (BBNX) Soars 10.3%: Is Further Upside Left in the Stock?
JPMorgan Chase & Co. Raises Stock Position in Beta Bionics, Inc. $BBNX
Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Beta Bionics (NASDAQ: BBNX)
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of “Moderate Buy” from Brokerages
First Eagle Investment Management LLC Buys Shares of 233,202 Beta Bionics, Inc. $BBNX
BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Lowest Quant ranked small-cap stocks with positive EPS surprises
BBNX INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX
Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026
BBNX SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX
Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc. - BBNX
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc. - BBNX
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR ALERT: Investigation of Beta Bionics, Inc. (BBNX) by Holzer & Holzer, LLC
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Beta Bionics, Inc. (NASDAQ: BBNX)
BBNX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
Beta Bionics, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - BBNX
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Beta Bionics (NASDAQ:BBNX) Trading Down 9.2% on Analyst Downgrade
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
Financial Comparison: Beta Bionics (NASDAQ:BBNX) and Tenon Medical (NASDAQ:TNON)
Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
Beta Bionics (NASDAQ:BBNX) Insider Mike Mensinger Sells 7,800 Shares
Beta Bionics (NASDAQ:BBNX) CFO Stephen Feider Sells 20,000 Shares
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026